- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Health Protection (Coronavirus, International Travel) (2021 Consolidation) (Amendment No. 8) Regulations (Northern Ireland) 2021 (revoked).
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Statutory Rules of Northern Ireland
Public Health
Made
30th October 2021
Coming into operation in accordance with regulations 1(2) and (3)
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
(This note is not part of the Regulations)
These Regulations amend the Health Protection (Coronavirus, International Travel) Regulations (Northern Ireland) 2021 (“the principal Regulations”).
Regulation 3. These amendments introduce lateral flow device (LFD) test for the detection of Coronavirus (SARS-CoV-2) as an alternative to existing requirements on arrivals deemed to be “eligible travellers” to undertake day 2 polymerase chain reaction (PCR) tests. The amendments provide for the use of LFD tests and the consequences of the results of such tests.
Regulation 4 amends regulation 3(3) to update the circumstances in which those arriving in a country or territory on an aircraft or vessel are not to be treated as having departed from, or transited through, that country or territory without first passing through immigration control.
Regulation 5 removes “Colombia”, “Dominican Republic”, “Ecuador”, “Haiti”, “Panama”, “Peru” and “Venezuela” from the red list of countries.
Regulation 6-
(a) extends the criteria for an “eligible arrival” to include participants in phase 2 or phase 3 clinical trials for a Coronavirus vaccine which is regulated by the European Medicines Agency or a regulatory authority (other than such an authority in the UK or USA) which is designated as a Stringent Regulatory Authority by the World Health Organisation;
(b) extends the circumstances in which a person is deemed to have completed a course of doses of an authorised vaccine. and
(c) adds the following 35 new countries Argentina; Angola; Azerbaijan; Belize; Botswana; Costa Rica; Djibouti, Eswatini; Guyana; Honduras; Lesotho; Mauritius; Mongolia; Nepal; Panama; Peru; Rwanda; Seychelles; Suriname; Tanzania; Trinidad and Tobago; Tunisia; Uganda; Uruguay; Anguilla; Armenia; Bermuda; Cambodia; Cayman Islands; Gibraltar; Lebanon; Madagascar; Occupied Palestinian Territories; Sierra Leone; Sri Lanka, to paragraph 12 of Schedule 2B (Criteria to be an eligible arrival).
Regulation 7 amends the circumstances relating to mandatory testing after arrival in Northern Ireland.
Regulation 8 amends Schedule 4 to the principal Regulations to remove the “no access to passengers” condition from the exemption from the requirement to provide information (regulation 4) for “Seamen and masters”, “Pilots (maritime)”, “Ship inspectors”, and “Air crew”; and to introduce an exemption from the requirement to provide information (regulation 4) for “Transit passenger” and “Road haulage worker”.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Rule and provides information about its policy objective and policy implications. They aim to make the Statutory Rule accessible to readers who are not legally qualified and accompany any Northern Ireland Statutory Rule or Draft Northern Ireland Statutory Rule laid before the UK Parliament during the suspension of the Northern Ireland Assembly.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: